Novel Microdevices, Inc. awarded up to $13.8 million from CARB-X
Novel Microdevices, Inc. awarded up to $13.8 million from CARB-X for the development of a rapid, point-of-care, molecular diagnostic platform for the detection of sexually transmitted diseases, including antibiotic-resistant infections To read more: